Seagen Inc. [SGEN] has reported $174.74 million loss for the fiscal quarter ending Mar 31, 2023.
Revenue for the quarter was $519.72 million with operating income of $184.51 million.
The Bothell, Washington (WA)-based company operating in the biological products, except diagnostic substances sector has total shareholders equity of $2,723.16 million.
Also read:
This is a developing story. Click
here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts
here. 
